Clinical Pharmacology and Drug Toxicity Practice Questions

Q: Which of the following is NOT an immunosuppressant?

Cephalosporin. **Explanation:** The correct answer is **A. Cephalosporin**. **1. Why Cephalosporin is the correct answer:** Cephalosporins are a class of **Beta-lactam antibiotics** used to treat bacterial infections. They work by inhibiting bacterial cell wall synthesis (binding to Penicillin-Binding Proteins). They have no inherent immunosuppressive properties; in fact, they are used to treat infections that may arise as a complication of immunosuppression. **2. Analysis of Incorrect Options (Immunosuppressants):** * **Cyclosporine:** A Calcineurin inhibitor. It binds to cyclophilin, inhibiting the transcription of Interleukin-2 (IL-2), which is essential for T-cell activation. It is a cornerstone drug in organ transplantation. * **Azathioprine:** A Purine antimetabolite (prodrug of 6-Mercaptopurine). It inhibits DNA synthesis, thereby suppressing the proliferation of rapidly dividing cells, particularly T and B lymphocytes. * **Steroids (Glucocorticoids):** These are broad-spectrum immunosuppressants. They inhibit the nuclear factor kappa-B (NF-κB) pathway, leading to decreased production of multiple pro-inflammatory cytokines (IL-1, IL-2, IL-6, TNF-α). **Clinical Pearls for NEET-PG:** * **Cyclosporine Side Effects:** Remember the "5 H's"—Hypertrichosis (hirsutism), Hyperplasia (gingival), Hypertension, Hyperlipidemia, and Hyperkalemia (along with Nephrotoxicity). * **Drug of Choice:** Steroids are often the first-line treatment for many autoimmune conditions, while Cyclosporine/Tacrolimus are preferred for preventing graft rejection. * **Azathioprine Interaction:** Always check for **Allopurinol** co-administration. Allopurinol inhibits Xanthine Oxidase, leading to toxic levels of 6-MP/Azathioprine and severe bone marrow suppression.

Q: Which of the following is a category X drug?

Isotretinoin. **Explanation:** The FDA Pregnancy Categories (A, B, C, D, and X) classify drugs based on their safety profile during pregnancy. **Category X** drugs are those where studies in animals or humans have demonstrated positive evidence of fetal abnormalities, and the risks involved clearly outweigh any potential benefits. **1. Why Isotretinoin is Correct:** Isotretinoin (a Vitamin A derivative used for severe acne) is a notorious **teratogen**. It is associated with "Retinoic Acid Embryopathy," characterized by craniofacial, cardiac, thymic, and CNS defects. Due to its high risk, it is strictly contraindicated in pregnancy, and female patients must adhere to the **iPLEDGE program**, requiring two forms of contraception and regular pregnancy tests. **2. Analysis of Incorrect Options:** * **Itraconazole (Category C):** Animal studies show toxicity, but human data is lacking. It should be used only if the benefit justifies the risk. * **Nitrofurantoin (Category B):** Generally considered safe in the first and second trimesters. However, it is avoided at term (38–42 weeks) due to the risk of hemolytic anemia in the newborn. * **Acyclovir (Category B):** Extensive clinical experience has shown it to be safe for treating herpes infections during pregnancy. **High-Yield Clinical Pearls for NEET-PG:** * **Other Category X Drugs:** Thalidomide (Phocomelia), Methotrexate, Statins, Warfarin (Fetal Warfarin Syndrome), and Misoprostol. * **ACE Inhibitors/ARBs:** These are **Category D** (cause renal dysgenesis and oligohydramnios) but are frequently tested alongside Category X drugs. * **Valproate:** Highly teratogenic (Neural Tube Defects); it is now often classified as Category X when used for migraine prophylaxis.

Q: Which of the following drugs is responsible for the teratogenic effect shown in the image?

Carbimazole. ***Carbimazole*** - Causes **aplasia cutis congenita**, a characteristic teratogenic effect involving congenital absence of skin, typically on the scalp as shown in the image. - Also associated with **choanal atresia** and **esophageal atresia** when used during pregnancy, making it contraindicated in the first trimester. *Propylthiouracil* - Generally considered **safer in pregnancy**, especially during the first trimester compared to carbimazole. - Does not typically cause **aplasia cutis congenita** and is the preferred antithyroid drug for pregnant women with hyperthyroidism. *Valproate* - Causes **neural tube defects** (spina bifida) and **fetal valproate syndrome** with characteristic facial dysmorphism. - Associated with developmental delays and autism spectrum disorders, but not aplasia cutis congenita. *Phenytoin* - Causes **fetal hydantoin syndrome** characterized by growth retardation, microcephaly, and distinctive facial features. - May cause **cleft lip/palate** and cardiac defects, but does not typically result in skin aplasia.

Q: A 14-year-old boy presents with weakness, muscle twitching, drooling, and a generalized tonic-clonic seizure after helping his father in the yard. On arrival of emergency medical services, his heart rate is 40 beats per minute and his pupils are pinpoint. What is the most appropriate treatment for the likely toxic substance involved?

Atropine and pralidoxime (2-PAM). ### Explanation **Diagnosis: Organophosphate (OP) Poisoning** The clinical presentation of **miosis (pinpoint pupils), bradycardia, drooling (salivation), and muscle twitching (fasciculations)** in the context of yard work strongly suggests exposure to Organophosphate insecticides. These agents irreversibly inhibit **Acetylcholinesterase (AChE)**, leading to an "acetylcholine storm" at both muscarinic and nicotinic receptors. **1. Why Option A is Correct:** * **Atropine:** A competitive muscarinic antagonist. It reverses life-threatening "wet" symptoms (bradycardia, bronchospasm, and secretions). It does **not** affect nicotinic receptors (muscle twitching). * **Pralidoxime (2-PAM):** A cholinesterase regenerator. It cleaves the phosphate group from the enzyme, restoring its function. Crucially, it treats **nicotinic** symptoms like muscle weakness and fasciculations. It must be given before "aging" (permanent enzyme-ligand bonding) occurs. **2. Why Other Options are Incorrect:** * **Option B (N-acetylcysteine):** The antidote for **Acetaminophen (Paracetamol)** toxicity; it restores glutathione stores. * **Option C (DMSA/Succimer):** A chelating agent used for **heavy metal poisoning** (e.g., Lead, Mercury, Arsenic). * **Option D (Naloxone):** An opioid antagonist. While opioid overdose causes pinpoint pupils and respiratory depression, it does **not** cause salivation or muscle fasciculations. **Clinical Pearls for NEET-PG:** * **DUMBELS Mnemonic:** Diarrhea, Urination, Miosis, Bradycardia/Bronchospasm, Emesis, Lacrimation, Salivation (Muscarinic effects). * **Atropinization Goal:** Titrate atropine until **secretions dry up** and **tachycardia** occurs; pupil size is a less reliable endpoint. * **Aging:** Once the OP-enzyme complex "ages," oximes (2-PAM) are no longer effective. * **Carbamate Poisoning:** Similar presentation, but oximes are generally not required as the enzyme inhibition is reversible.

Q: Which secretion is not decreased in organophosphate poisoning?

Sweat. ### Explanation **Concept:** Organophosphate (OP) poisoning inhibits the enzyme **Acetylcholinesterase**, leading to an accumulation of Acetylcholine (ACh) at both muscarinic and nicotinic receptors. This results in a "cholinergic crisis," characterized by generalized overstimulation of secretory glands. **Why Sweat is the Correct Answer:** The question asks which secretion is **NOT decreased**. In OP poisoning, almost all bodily secretions **increase**. Therefore, sweating (diaphoresis) is a classic clinical feature of OP poisoning. Sweat glands are unique because, although they are part of the Sympathetic Nervous System, they are innervated by **cholinergic fibers** (muscarinic receptors). The excess ACh causes profuse sweating. *Note: If the question intended to ask which secretion is "not increased," the options provided would be logically inconsistent. In the context of OP poisoning, all listed options (Sweat, Saliva, Nasal secretions, and Urine) actually **increase**.* **Analysis of Incorrect Options:** * **B. Saliva:** OP poisoning causes hypersalivation (Sialorrhea) due to muscarinic overstimulation. * **C. Nasal secretions:** Increased lacrimation and rhinorrhea are standard components of the cholinergic toxidrome. * **D. Urine:** OP poisoning leads to involuntary urination (detrusor contraction) as part of the "DUMBELS" mnemonic. **NEET-PG High-Yield Pearls:** * **Mnemonic for OP Poisoning (Muscarinic effects):** **DUMBELS** (Diarrhea, Urination, Miosis, Bradycardia/Bronchospasm, Emesis, Lacrimation, Salivation/Sweating). * **Management:** The specific antidote is **Atropine** (reverses muscarinic effects) and **Pralidoxime (2-PAM)**, which regenerates the cholinesterase enzyme if given before "aging" occurs. * **Death in OP poisoning** is most commonly due to respiratory failure (bronchospasm + increased bronchial secretions + diaphragmatic paralysis).

Q: Which of the following immunosuppressant drugs is nephrotoxic?

Tacrolimus. **Explanation:** **Tacrolimus** is a **Calcineurin Inhibitor (CNI)**, a class of drugs notorious for causing **nephrotoxicity**. The mechanism involves potent vasoconstriction of the afferent arterioles in the kidney, leading to reduced renal blood flow and a decreased Glomerular Filtration Rate (GFR). Chronic use can lead to irreversible interstitial fibrosis and tubular atrophy. Both Tacrolimus and Cyclosporine share this dose-limiting toxicity. **Analysis of Incorrect Options:** * **A. Azathioprine:** A purine analog (antimetabolite) primarily known for **bone marrow suppression** (leukopenia) and hepatotoxicity. It is generally considered renal-safe. * **B. Cyclophosphamide:** An alkylating agent. Its hallmark toxicity is **Hemorrhagic Cystitis** (caused by the metabolite Acrolein), not direct nephrotoxicity. It can also cause SIADH and infertility. * **C. Mycophenolate Mofetil (MMF):** An inhibitor of IMPDH. Its primary side effects are **gastrointestinal** (diarrhea, abdominal pain) and hematological (anemia, leukopenia). It is often used as a "renal-sparing" alternative to CNIs. **High-Yield Clinical Pearls for NEET-PG:** * **CNI Toxicity Profile:** While both cause nephrotoxicity, **Tacrolimus** is more likely to cause **Post-Transplant Diabetes Mellitus (PTDM)** and neurotoxicity (tremors), whereas **Cyclosporine** is more associated with **gingival hyperplasia** and **hirsutism**. * **Drug Interaction:** CNIs are metabolized by **CYP3A4**. Co-administration with Ketoconazole (inhibitor) increases toxicity, while Rifampicin (inducer) decreases efficacy. * **Monitoring:** Therapeutic Drug Monitoring (TDM) is mandatory for Tacrolimus to prevent renal damage.

Q: Cyclosporine acts by decreasing the production of:

IL-2. Cyclosporine is a potent immunosuppressant categorized as a **Calcineurin Inhibitor**. Its primary mechanism of action involves binding to an intracellular protein called **Cyclophilin**. This Cyclosporine-Cyclophilin complex inhibits **Calcineurin**, a phosphatase enzyme required for the dephosphorylation of the **Nuclear Factor of Activated T-cells (NFAT)**. Without dephosphorylation, NFAT cannot translocate into the nucleus to promote the transcription of pro-inflammatory cytokines. The most significant result of this inhibition is the **decreased production of Interleukin-2 (IL-2)** [1]. Since IL-2 is the primary growth factor for T-cell proliferation and differentiation, its suppression leads to a profound decrease in the cell-mediated immune response [1]. **Analysis of Incorrect Options:** * **IL-1:** Primarily produced by macrophages and monocytes; its production is more significantly affected by corticosteroids rather than calcineurin inhibitors [3]. * **IL-6 and IL-8:** These are pro-inflammatory cytokines and chemotactic factors involved in acute phase responses and neutrophil recruitment. While cyclosporine may have minor downstream effects on various cytokines, its **primary and direct** molecular target is the IL-2 gene transcription process. **High-Yield Clinical Pearls for NEET-PG:** * **Therapeutic Uses:** Prevention of graft-versus-host disease (GVHD) in organ transplants, Rheumatoid Arthritis, and Psoriasis [4]. * **Side Effects (The "H" Rule):** **H**ypertension, **H**yperplasia of gums (Gingival hyperplasia), **H**irsutism, and **H**yperkalemia [4]. * **Major Toxicity:** Nephrotoxicity (most common dose-limiting toxicity) and Neurotoxicity (tremors) [4]. * **Drug Interactions:** It is metabolized by CYP3A4; therefore, Grapefruit juice (inhibitor) increases its toxicity, while Rifampicin (inducer) decreases its efficacy [2].

Q: Naltrexone is used for which of the following poisonings?

Heroin. **Explanation:** **Naltrexone** is a long-acting, competitive **opioid receptor antagonist** with high affinity for μ (mu) receptors. **1. Why Heroin is correct:** Heroin is an opioid prodrug that is rapidly converted to morphine, acting on μ-receptors to produce euphoria and respiratory depression. Naltrexone blocks these receptors, preventing the "high" associated with opioid use. While **Naloxone** is the drug of choice for *acute* opioid overdose (due to its rapid onset and IV formulation), **Naltrexone** is primarily used in the **maintenance phase of opioid de-addiction** to prevent relapse, as it has a long half-life (up to 24–48 hours) and is orally effective. **2. Why the other options are incorrect:** * **Atropine:** This is an anticholinergic drug. Its toxicity (anticholinergic syndrome) is treated with **Physostigmine** (a reversible acetylcholinesterase inhibitor). * **Cannabis:** There is no specific pharmacological antagonist for cannabis. Management is primarily supportive (e.g., benzodiazepines for agitation). * **Diazepam:** This is a benzodiazepine (BZD). The specific antagonist for BZD overdose is **Flumazenil**, which acts on the GABA-A receptor complex. **Clinical Pearls for NEET-PG:** * **Naltrexone vs. Naloxone:** Remember "Nal**o**xone is for **O**verdose (Acute)" and "Naltre**x**one is for e**X**-addicts (Maintenance)." * **Alcoholism:** Naltrexone is also FDA-approved for **Alcohol Dependence**; it reduces the "reward" pathway by blocking endogenous opioid-mediated dopamine release in the nucleus accumbens. * **Contraindication:** Never administer Naltrexone to a patient currently dependent on opioids without a washout period (7–10 days), as it will precipitate **severe withdrawal symptoms**.

Q: What is the active metabolite of azathioprine?

6-mercaptopurine. **Explanation:** **Azathioprine** is a prodrug belonging to the class of purine antimetabolites (immunosuppressants). After administration, it undergoes non-enzymatic cleavage by glutathione in the liver and red blood cells to release its active form, **6-mercaptopurine (6-MP)** [1], [4]. 6-MP is further metabolized into thio-inosinic acid, which inhibits the synthesis of adenine and guanine nucleotides, thereby suppressing T-cell and B-cell proliferation [1]. This makes it highly effective in preventing organ transplant rejection [2] and managing autoimmune conditions like SLE and Crohn’s disease [4]. **Analysis of Options:** * **Option A (6-thioguanine):** This is a separate purine analog used primarily in acute myeloid leukemia [1]. While 6-MP can eventually be converted into thioguanine nucleotides (TGNs) downstream, 6-MP is the immediate active metabolite of azathioprine [1]. * **Option B (6-thiouracil):** This is not a metabolite of azathioprine; it is structurally related to pyrimidines and antithyroid drugs (like Propylthiouracil). * **Option D (6-mercaptoguanine):** This is an incorrect chemical name in this metabolic context. **High-Yield Clinical Pearls for NEET-PG:** 1. **Drug Interaction:** 6-MP is metabolized by the enzyme **Xanthine Oxidase** [3]. **Allopurinol** (a xanthine oxidase inhibitor) significantly increases the levels of 6-MP, leading to life-threatening bone marrow suppression [3]. The dose of azathioprine must be reduced by 75% if given with allopurinol. 2. **Pharmacogenomics:** Patients with a genetic deficiency of the enzyme **TPMT (Thiopurine Methyltransferase)** are at a high risk of severe toxicity (pancytopenia) when taking azathioprine. 3. **Side Effects:** The most common dose-limiting toxicity is **bone marrow suppression** (leukopenia) [2].

Q: Which of the following statements about fexofenadine is true?

It does not block cardiac K+ channels.. **Explanation:** **Fexofenadine** is a second-generation (non-sedating) H1 antihistamine. The correct answer is **Option C** because fexofenadine is the active metabolite of **terfenadine**. Unlike its parent drug, fexofenadine does not block the delayed rectifier potassium (K+) channels in the myocardium. Consequently, it does not cause QT interval prolongation or the life-threatening ventricular arrhythmia known as *Torsades de Pointes*. **Analysis of Incorrect Options:** * **Option A:** Fexofenadine does not undergo significant hepatic metabolism. It is primarily excreted unchanged in the feces and urine, making it safer for patients with liver dysfunction. * **Option B:** This is reversed. **Fexofenadine is the active metabolite of terfenadine.** Terfenadine was withdrawn from the market because it was a pro-drug that blocked K+ channels; if its metabolism was inhibited (e.g., by erythromycin or ketoconazole), toxic levels led to cardiac toxicity. * **Option D:** As a second-generation antihistamine, fexofenadine has **low lipid solubility** and is a substrate for the P-glycoprotein efflux pump. Therefore, it does not cross the blood-brain barrier significantly and has a very low affinity for central H1 receptors, making it "non-sedating." **NEET-PG High-Yield Pearls:** * **Cardiac Safety:** Fexofenadine and Loratadine are the safest second-generation antihistamines regarding cardiac side effects. * **Astemizole and Terfenadine:** Both were withdrawn globally due to the risk of *Torsades de Pointes*. * **Drug Interactions:** Avoid taking fexofenadine with fruit juices (like grapefruit or orange) as they inhibit OATP1A2, reducing the drug's absorption.

Question 1

Which of the following is NOT an immunosuppressant?

Accepted Answer

Cephalosporin

Answer

Cyclosporine

Answer

Azathioprine

Answer

Steroids

Question 2

Which of the following is a category X drug?

Accepted Answer

Isotretinoin

Answer

Itraconazole

Answer

Nitrofurantoin

Answer

Acyclovir

Question 3

Which of the following drugs is responsible for the teratogenic effect shown in the image?

Accepted Answer

Carbimazole

Answer

Propylthiouracil

Answer

Valproate

Answer

Phenytoin

Question 4

A 14-year-old boy presents with weakness, muscle twitching, drooling, and a generalized tonic-clonic seizure after helping his father in the yard. On arrival of emergency medical services, his heart rate is 40 beats per minute and his pupils are pinpoint. What is the most appropriate treatment for the likely toxic substance involved?

Accepted Answer

Atropine and pralidoxime (2-PAM)

Answer

N-acetylcysteine (Mucomyst)

Answer

Dimercaptosuccinic acid (DMSA, succimer)

Answer

Naloxone (Narcan)

Question 5

Which secretion is not decreased in organophosphate poisoning?

Accepted Answer

Sweat

Answer

Saliva

Answer

Nasal secretions

Answer

Urine

Question 6

Which of the following immunosuppressant drugs is nephrotoxic?

Accepted Answer

Tacrolimus

Answer

Azathioprine

Answer

Cyclophosphamide

Answer

Mycophenolate mofetil

Question 7

Cyclosporine acts by decreasing the production of:

Accepted Answer

IL-2

Answer

IL-1

Answer

IL-6

Answer

IL-8

Question 8

Naltrexone is used for which of the following poisonings?

Accepted Answer

Heroin

Answer

Atropine

Answer

Cannabis

Answer

Diazepam

Question 9

What is the active metabolite of azathioprine?

Accepted Answer

6-mercaptopurine

Answer

6-thioguanine

Answer

6-thiouracil

Answer

6-mercaptoguanine

Question 10

Which of the following statements about fexofenadine is true?

Accepted Answer

It does not block cardiac K+ channels.

Answer

It undergoes high first-pass metabolism in the liver.

Answer

Terfenadine is an active metabolite of this drug.

Answer

It has a high affinity for central H1 receptors.

Clinical Pharmacology and Drug Toxicity — MCQs

Clinical Pharmacology and Drug Toxicity — MCQs

On this page

Practice by Chapter

Want unlimited practice?